Federal Register / Vol. 62, No. 191 / Thursday, October 2, 1997 / Notices 51669

be kept in an active file for two years.

New hire information will then be

stored for an additional three years

before being destroyed.

Tax refund and administrative offset

information will be maintained for six

years in an active master file for

purposes of collection and adjustment.

After this time, records of cases for

which there was no collection will be

destroyed. Records of cases with a

collection will be stored on-line in an

inactive master file.

Records pertaining to passport denial

will be updated and/or deleted as

obligors meet satisfactory restitution or

other State approved arrangements.

Records of information provided by

the FPLS to authorized users will be

maintained only long enough to

communicate the information to the

appropriate State or Federal agent.

Thereafter, the information provided

will be destroyed. However, records

pertaining to the disclosures, which

include information provided by States,

Federal agencies contacted, and an

indication of the type(s) of information

returned, will be stored on a history

tape and in hard copy for five years and

then destroyed.

SYSTEM MANAGER(S) AND ADDRESS:

Director, Division of Program

Operations Office of Child Support

Enforcement Administration for

Children and Families 370 L’Enfant

Promenade, SW., 4th Floor East

Washington, DC. 20447.

NOTIFICATION PROCEDURES:

To determine if a record exists, write

to the System Manager listed above. The

requester must provide his or her full

name and address. Additional

information, such as your Social

Security Number, date of birth or

mother’s maiden name, may be

requested by the system manager in

order to distinguish between

individuals having the same or similar

names.

RECORD ACCESS PROCEDURES:

Write to the System Manager

specified above to attain access to

records. Requesters should also

reasonably specify the record contents

they are seeking.

CONTESTING RECORD PROCEDURE:

Contact the official at the address

specified under system manager above,

and reasonably identify the record and

specify the information to be contested

and corrective action sought with

supporting justification to show how the

record is inaccurate, incomplete,

untimely or irrelevant.

RECORD SOURCE CATEGORIES:

Information is obtained from

departments, agencies, or

instrumentalities of the United States or

any State.

SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS

OF THE ACT:

None.

[FR Doc. 97–26049 Filed 10–1–97; 8:45 am]

BILLING CODE 4184–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). At least one portion of the

meeting will be closed to the public.

Name of Committee: Circulatory

System Devices Panel of the Medical

Devices Advisory Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on FDA

regulatory issues.

Date and Time: The meeting will be

held on October 24, 1997, 9:30 a.m. to

6 p.m.

Location: Gaithersburg Marriott

Washingtonian Center, Salons C and D,

9751 Washingtonian Blvd.,

Gaithersburg, MD.

Contact Person: John E. Stuhlmuller,

Center for Devices and Radiological

Health (HFZ–450), Food and Drug

Administration, 9200 Corporate Blvd.,

Rockville, MD 20850, 301–443–8243,

ext. 157, or FDA Advisory Committee

Information Line, 1–800–741–8138

(301–443–0572 in the Washington, DC

area), code 12625. Please call the

Information Line for up-to-date

information on this meeting.

Agenda: The committee is being

asked to provide input to the agency

regarding the design of clinical trials to

support premarket approval

applications for devices intended to

treat atrial septal defects, patent

foramen ovale, and patent ductus

arteriosus. Of particular concern are the

following issues: What are the

appropriate controls to be used in such

trials? What are the appropriate safety

and efficacy measures? When should

assessments of these measures be made?

Procedure: On October 24, 1997, from

12:30 p.m. to 6 p.m., the meeting is

open to the public. Interested persons

may present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by October 14, 1997. Oral

presentations from the public will be

scheduled between approximately 12:30

p.m. and 1:30 p.m. Time allotted for

each presentation may be limited. Those

desiring to make formal oral

presentations should notify the contact

person before October 14, 1997, and

submit a brief statement of the general

nature of the evidence or arguments

they wish to present, the names and

addresses of proposed participants, and

an indication of the approximate time

requested to make their presentation.

Closed Committee Deliberations: On

October 24, 1997, from 9:30 a.m. to

12:30 p.m., the meeting will be closed

to permit discussion and review of trade

secret and/or confidential information

(5 U.S.C. 552b(c)(4)). FDA staff will

present trade secret and/or confidential

information regarding pending and

future circulatory system device

submissions.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: September 25, 1997.

Michael A. Friedman,

Deputy Commissioner for Operations.

[FR Doc. 97–26113 Filed 10–1–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[HCFA–382]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

AGENCY: Health Care Financing

Administration, HHS.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated